REGISTRAT-MAPI provides strategic and operational expertise
to design and implement Late Phase studies.

Because of unique strategic and operational aspects of each study, we are committed to developing true partnerships with our biopharmaceutical and medical device company clients. REGISTRAT-MAPI is the industry’s largest clinical research organization (CRO) dedicated solely to “real-world” clinical research.

Our resources in North America, Europe, and Asia are focused on providing our clients with services of utmost quality and helping them advance scientific knowledge, gain clinical insights, and optimize healthcare effectiveness, safety, and utilization. Most importantly, these resources as well as the systems and processes that support them, have been assembled with a singular intent–to provide the best in Late Phase research strategy and execution. REGISTRAT-MAPI is a powerful partner to help you meet the increasing demand to design and conduct registries, observational and epidemiological studies, and Risk Management Programs (REMS and EU-RMPs). We conduct high-quality studies, grounded in sound clinical and biostatistical principles. We believe in sharing responsibility with our clients to advance research efforts for their products to impact quality of patient care.

 

Our new comprehensive website will be released in February 2010.

Please check back then for more details.